INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding car… Read more
INSPIREMD 1/18 DL-0001 (II2) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INSPIREMD 1/18 DL-0001 (II2) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INSPIREMD 1/18 DL-0001 - Net Assets Trend (None–None)
This chart illustrates how INSPIREMD 1/18 DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INSPIREMD 1/18 DL-0001 (None–None)
The table below shows the annual net assets of INSPIREMD 1/18 DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INSPIREMD 1/18 DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INSPIREMD 1/18 DL-0001 Competitors by Market Cap
The table below lists competitors of INSPIREMD 1/18 DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Media Capital SGPS S.A
MU:GQV
|
$27.64 Million |
|
Adveritas Ltd
AU:AV1
|
$27.64 Million |
|
Siili Solutions Oyj
HE:SIILI
|
$27.65 Million |
|
Daehan Synthet
KO:003830
|
$27.66 Million |
|
ROYAL ROAD MIN.
F:RLU
|
$27.62 Million |
|
Pungguk Ethanol Industrial Co. Ltd
KQ:023900
|
$27.62 Million |
|
Jaya Konstruksi Manggala Pratama
JK:JKON
|
$27.61 Million |
|
Lakes Oil NL
AU:LKO
|
$27.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INSPIREMD 1/18 DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INSPIREMD 1/18 DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INSPIREMD 1/18 DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INSPIREMD 1/18 DL-0001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INSPIREMD 1/18 DL-0001 (II2) | €- | N/A | N/A | $27.63 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |